Nordea Investment Management AB Has $1.21 Million Stock Holdings in The Cooper Companies, Inc. $COO

Nordea Investment Management AB boosted its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 7.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 16,976 shares of the medical device company’s stock after buying an additional 1,243 shares during the period. Nordea Investment Management AB’s holdings in Cooper Companies were worth $1,209,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Zions Bancorporation National Association UT acquired a new position in Cooper Companies during the first quarter worth $33,000. J.Safra Asset Management Corp raised its holdings in shares of Cooper Companies by 204.8% in the second quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company’s stock valued at $36,000 after purchasing an additional 340 shares during the last quarter. GKV Capital Management Co. Inc. purchased a new stake in shares of Cooper Companies in the first quarter valued at about $40,000. Larson Financial Group LLC raised its holdings in shares of Cooper Companies by 1,071.0% in the first quarter. Larson Financial Group LLC now owns 726 shares of the medical device company’s stock valued at $61,000 after purchasing an additional 664 shares during the last quarter. Finally, HM Payson & Co. raised its holdings in shares of Cooper Companies by 147.4% in the first quarter. HM Payson & Co. now owns 893 shares of the medical device company’s stock valued at $75,000 after purchasing an additional 532 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Trading Up 0.1%

Shares of COO opened at $74.52 on Friday. The firm’s 50 day simple moving average is $69.67 and its 200 day simple moving average is $73.22. The company has a market capitalization of $14.82 billion, a P/E ratio of 36.71, a P/E/G ratio of 1.95 and a beta of 1.02. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.24. The Cooper Companies, Inc. has a 1-year low of $61.78 and a 1-year high of $109.04.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, beating analysts’ consensus estimates of $1.07 by $0.03. The business had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. Cooper Companies’s quarterly revenue was up 5.7% on a year-over-year basis. During the same period last year, the firm posted $0.96 earnings per share. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies declared that its Board of Directors has initiated a stock repurchase program on Wednesday, September 17th that permits the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization permits the medical device company to reacquire up to 15.4% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board believes its shares are undervalued.

Insider Activity

In other Cooper Companies news, Director Lawrence Erik Kurzius purchased 2,000 shares of the firm’s stock in a transaction on Monday, September 29th. The shares were purchased at an average cost of $68.39 per share, with a total value of $136,780.00. Following the completion of the purchase, the director owned 5,777 shares of the company’s stock, valued at $395,089.03. The trade was a 52.95% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Albert G. White III bought 10,000 shares of the business’s stock in a transaction dated Friday, September 5th. The stock was purchased at an average price of $68.39 per share, for a total transaction of $683,900.00. Following the acquisition, the chief executive officer directly owned 226,151 shares of the company’s stock, valued at approximately $15,466,466.89. The trade was a 4.63% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders bought 17,975 shares of company stock valued at $1,216,346. Insiders own 1.98% of the company’s stock.

Wall Street Analysts Forecast Growth

COO has been the subject of several analyst reports. BNP Paribas Exane upgraded shares of Cooper Companies from a “neutral” rating to an “outperform” rating and set a $92.00 target price for the company in a report on Tuesday, July 22nd. Mizuho lowered their target price on shares of Cooper Companies from $105.00 to $90.00 and set an “outperform” rating for the company in a report on Wednesday, July 16th. JPMorgan Chase & Co. reduced their price target on shares of Cooper Companies from $76.00 to $66.00 and set a “neutral” rating for the company in a research report on Thursday, August 28th. Wells Fargo & Company reduced their price target on shares of Cooper Companies from $93.00 to $72.00 and set an “overweight” rating for the company in a research report on Thursday, August 28th. Finally, Barclays began coverage on shares of Cooper Companies in a research report on Monday, October 13th. They set an “overweight” rating and a $85.00 price target for the company. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Cooper Companies presently has a consensus rating of “Moderate Buy” and a consensus target price of $84.77.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.